
Every month, Stanford Parkinson’s Community Outreach produces a list of Parkinson’s-related webinars and virtual meetings with speakers. Here’s our July 2026 list.
… Full Story>
Every month, Stanford Parkinson’s Community Outreach produces a list of Parkinson’s-related webinars and virtual meetings with speakers. Here’s our July 2026 list.
… Full Story>
Todos los meses, Stanford Parkinson’s Community Outreach producirá una lista de seminarios web y reuniones virtuales en español relacionados con el Parkinson con oradores. Aquí está nuestra lista de Julio de 2026.
… Full Story>
At the end of May 2026, Stanford Medicine hosted a webinar titled “Atypical Parkinsonian Disorders: Outreach, Access, and Education,” bringing together neurologists and other healthcare professionals to address the diagnosis and multidisciplinary management of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)/corticobasal syndrome (CBS). This webinar was continuing medical education for physicians and other healthcare providers.
… Full Story>
In May 2026, The Caring Neurologist podcast series featured an episode on swallowing difficulties in Parkinson’s disease. Sandeep Thakkar, DO, a movement disorder specialist in Southern California, talks about why swallowing problems occur, how to recognize early warning signs, and practical strategies for patients and families to maintain safety and quality of life. Swallowing difficulties are often overlooked in conversations about Parkinson’s but can have serious, even life-threatening consequences if missed.
… Full Story>
Carbidopa/levodopa is the mainstay of treatment for Parkinson’s disease (PD) and is currently the most effective medication available for PD. Over time, many formulations of this medication have been developed which can make it confusing for people who are trying to understand which version of the medication is best for them. These APDA resources can help you better understand what this medication is, why it works, the different formulations available, and much more.
… Full Story>